✦ LIBER ✦

Cyclophosphamide-mediated enhancement of antitumor immune potential of immunosuppressed spleen cells from mice bearing a large MOPC-315 tumor

✍ Scribed by Margalit B. Mokyr; Michael Colvin; Sheldon Dray

Publisher: Elsevier Science
Year: 1985
Tongue: English
Weight: 953 KB
Volume: 7
Category: Article
ISSN: 0192-0561
DOI: 10.1016/0192-0561(85)90016-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Melphalan-mediated potentiation of antit

Melphalan-mediated potentiation of antitumor immune responsiveness of immunosuppressed spleen cells from mice bearing a large MOPC-315 tumor

✍ Robert C. Bocian; Shlomo Ben-Efraim; Sheldon Dray; Margalit B. Mokyr 📂 Article 📅 1984 🏛 Springer-Verlag 🌐 English ⚖ 927 KB

Administration of a low dose of L-PAM (0.75 mg/kg) to mice bearing a large SC MOPC-315 tumor and extensive metastases led to the development of augmented antitumor immune potential in their hitherto immunosuppressed spleen cells. Such drug-induced potentiation of antitumor immune responsiveness appe

Suppression of antitumor immunity by mac

Suppression of antitumor immunity by macrophages in spleens of mice bearing a large MOPC-315 tumor

✍ Qing-Wei Ye; Margalit B. Mokyr; Joseph M. Pyle; Sheldon Dray 📂 Article 📅 1984 🏛 Springer-Verlag 🌐 English ⚖ 928 KB

Effect of low-dose cyclophosphamide ther

Effect of low-dose cyclophosphamide therapy on specific and nonspecific T cell-dependent immune responses of spleen cells from mice bearing large MOPC-315 plasmacytomas

✍ James A. Wise; Margalit B. Mokyr; Sheldon Dray 📂 Article 📅 1988 🏛 Springer-Verlag 🌐 English ⚖ 770 KB

Some T cell-dependent immune parameters were examined in mice bearing a large MOPC-315 plasmacytoma before and after treatment with a low dose (15 mg/kg) of CY. Prior to CY therapy, spleen cells from mice bearing a large MOPC-315 tumor were depressed in their ability to generate an in vitro cytotoxi

Some approaches to improve the therapeut

Some approaches to improve the therapeutic effectiveness of adoptive chemoimmunotherapy with spleen cells from melphalan-treated BALB/C mice bearing a large MOPC-315 tumor

✍ Larry M. Weiskirch; Margalit B. Mokyr 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 1020 KB

## Abstract Spleen cells from BALB/c mice that are in the process of eradicating a large MOPC‐315 tumor following low‐dose L‐PAM therapy (L‐PAM TuB spleen cells) were previously shown to be capable of bringing about the complete regression of a large (15 to 20 mm) s.c. MOPC‐315 tumor in a substanti